ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
62.790,09
-1,49%
Brent Oil
88,165
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Five Prime Therapeutics Inc (FPRX)

  7. Five Prime Therapeutics Inc (FPRX) Notícias

FPRX

Five Prime Therapeutics (FPRX)

Five Prime Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FPRX
DataHoraFonteTítuloCódigoCompanhia
15/02/202208:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FPRXFive Prime Therapeutics Inc
22/04/202107:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FPRXFive Prime Therapeutics Inc
20/04/202112:28TipRanksAmgen Completes The Acquisition Of Five Prime TherapeuticsNASDAQ:FPRXFive Prime Therapeutics Inc
19/04/202120:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202117:16Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202117:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202109:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202109:43Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202109:39Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202109:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202109:25PR Newswire (US)Amgen Successfully Completes Acquisition Of Five Prime TherapeuticsNASDAQ:FPRXFive Prime Therapeutics Inc
18/03/202109:02Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:FPRXFive Prime Therapeutics Inc
09/03/202119:00Business WireFive Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference CallNASDAQ:FPRXFive Prime Therapeutics Inc
08/03/202119:02Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:FPRXFive Prime Therapeutics Inc
05/03/202118:20Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:FPRXFive Prime Therapeutics Inc
05/03/202105:57TipRanksAmgen Inks $1.9B Deal To Buy Five Prime Therapeutics; Shares Pop 79%NASDAQ:FPRXFive Prime Therapeutics Inc
04/03/202117:34Dow Jones NewsFive Prime Therapeutics Shares Gain After Amgen DealNASDAQ:FPRXFive Prime Therapeutics Inc
04/03/202111:20Dow Jones NewsAmgen to Acquire Five Prime Therapeutics for $1.9 Billion in CashNASDAQ:FPRXFive Prime Therapeutics Inc
04/03/202110:30PR Newswire (US)Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in CashNASDAQ:FPRXFive Prime Therapeutics Inc
02/03/202118:05Business WireFive Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference CallNASDAQ:FPRXFive Prime Therapeutics Inc
26/02/202119:00Business WireFive Prime Therapeutics to Participate in the Cowen 41st Annual Health Care ConferenceNASDAQ:FPRXFive Prime Therapeutics Inc
22/02/202120:00Business WireFive Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare ConferenceNASDAQ:FPRXFive Prime Therapeutics Inc
16/02/202118:47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FPRXFive Prime Therapeutics Inc
05/02/202111:25Business WireFive Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology DayNASDAQ:FPRXFive Prime Therapeutics Inc
15/01/202108:55Business WirePhase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression & Reinforce Potential of Bemari...NASDAQ:FPRXFive Prime Therapeutics Inc
09/12/202019:00Business WireFive Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab at American Society of Clinical Oncology (ASCO) Gastrointe...NASDAQ:FPRXFive Prime Therapeutics Inc
17/11/202019:00Business WireFive Prime Announces Closing of Upsized Public Offering of Common StockNASDAQ:FPRXFive Prime Therapeutics Inc
13/11/202019:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FPRXFive Prime Therapeutics Inc
13/11/202000:00Business WireFive Prime Announces Pricing of Upsized Public Offering of Common StockNASDAQ:FPRXFive Prime Therapeutics Inc
12/11/202008:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:FPRXFive Prime Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FPRX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
MATD3
Hospital Mater Dei S.A ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
GOLL4
GOL PN
BOV
PDTC3
Padtec ON
BOV
OIBR3
OI ON
BOV
PDGR3
PDG REALT ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
UNIP6
UNIPAR PNB
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados